Methylprednisolone suleptanate

Drug Profile

Methylprednisolone suleptanate

Alternative Names: Medrosol; PNU 67590A; Promedrol; U 67590A

Latest Information Update: 05 May 2004

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pfizer
  • Class Anti-inflammatories; Antiasthmatics; Corticosteroids
  • Mechanism of Action Immunosuppressants; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Asthma; Lupus nephritis; Nephrotic syndrome; Renal transplant rejection; Shock; Spinal cord injuries

Most Recent Events

  • 05 May 2004 No development reported - Phase-II for Lupus nephritis (Injection)
  • 05 May 2004 No development reported - Phase-III for Asthma in Japan (Injection)
  • 05 May 2004 No development reported - Preclinical for Spinal cord injuries (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top